Immuno Cytokines and Cell Markers Flashcards
IFN-α and IFN-β
Released by:
3 Effects:
Released by phagocytes in response to TLR-3 binding viral dsRNA
o Protects uninfected cells (inhibits translation of viral mRNA)
o Activates NK cells (kill virus infected cells)
o Increase expression of MHC class I (promote killing by Tc cells)
IFN-γ
Produced by:
4 Effects:
Involved in:
Inhibited by:
(Kong’s Tumor Immuno)
Produced by TH1 cells
o Activates macrophages and NK cells
o Upregulates MHC class II
o Induces B cells to produce IgG3 (complement)
o Inhibits formation of TH2 and TH17 cells
Involved in class switching
Inhibited by cyclosporine and tacrolimus
Produced by NK cells (Kong’s Tumor Immunity lecture)
IL-1
Released by:
Local and systemic effects:
PROINFLAMMATORY
Released by activated macrophages; released by dendritic cells in response to uptake of infectious agents
o Local: activates endothelium and lymphocytes
o Systemic: induces fever and stimulates IL-6 production
IL-2
Growth factor for:
Produced by:
Interaction of CD28 and B7 does what?
Effects of B7 interaction:
Production decreased by:
Inhibited by:
Growth factor for T cells (CD4, CD8) and NK cells
Produced by CD4+ cells (TH1) and SOME CD8+ cells
- Discrepancy between Kong and Sundick’s notes
- Sundick’s response: some CD8+ T cells produce IL-2 and therefore do not need CD4 to provide it
Interaction of CD28 (T cells) and B7 (APCs) stimulates T cell and its production of IL2
B7 interaction:
- Increases transcription of IL-2 mRNA
- Increases half-life of IL-2 mRNA
Production decreased by interaction of CTLA4 and B7
Inhibited by cyclosporine and tacrolimus
IL-3
Macrophage differentiation in the bone marrow (similar to GM-CSF)
IL-4
What stimulates synthesis?
Effects from TH2?
Involved in:
Gene clusters involved in:
Effects in Type I hypersensitivity
Inhibited by:
Parasitic worms and allergens stimulate synthesis of IL-4, promoting formation of TH2 cells
TH2 cells release IL-4
- Induces B cells to produce IgE and IgG4 (along with IL-13)
- Prevents development of TH1 and TH17 cells
Involved in class switching
IL4 gene cluster possibly involved in genetic component of allergy
Released as a preformed substance from mast cells during type I hypersensitivity
Inhibited by cyclosporine and tacrolimus
IL-5
Released by:
Growth factor for:
Released by TH2 cells
-Growth factor for eosinophils
Released as a preformed substance by mast cells during type I hypersensitivity
IL-6
Released by:
Local and systemic effects
PROINFLAMMATORY
Released by activated macrophages
- Local: activates lymphocytes and increases Ab production
- Systemic: induces fever; induces liver to produce acute phase proteins (CRP, MBL, SPA, SPB-opsonize bacteria, activate complement)
IL-7
Effects on T and B cells
Required for development of B cells from stem cells (along with stromal cells)
Required for development of T cells in the thymus (along with contact from dendritic and epithelial cells)
IL-8
Released by:
Released by activated macrophages
- Chemokine that attracts PMNs, basophils and T cells
Released as a preformed substance in mast cell granules during Type I hypersensitivity
- Chemokine that attracts PMNs
IL-10
Suppresses:
Released by:
Release of IL-10 + TGF-β by Treg cells suppresses the formation of TH1, TH2 and TH17 cells
Activated TH2 cells released TGF-β, IL-4 and IL-10 [discrepancy between Kong and Sundick]
IL-12
Released by:
Activates and induces:
(Kong’s lecture)
Released by activated macrophages; released by dendritic cells in response to uptake of infectious agents
- Activates NK cells (kill virus infected and tumor cells; cells that are deficient in MHC I)
- Induces CD4+ TH0 cells to become TH1 cells
Produced by NK cells (Kong’s Tumor Immunity lecture)
IL-13
Released by TH2 cells
o Induces B cells to produce IgE and IgG4 (along with IL-4)
IL-17+ IL-22
Released by TH17 cells
- Recruit and activate PMNs
- Induce epithelial cells to produce proinflammatory cytokines (IL1, IL6, TNFα)
IL-21
Release of IL-21 + TGF-β by dendritic cells leads to formation of TH17 cells
TGF-β
Dendritic cells release in combo:
Alone:
Treg release:
2 other cells release:
Release of IL-21 + TGF-β by dendritic cells leads to formation of TH17 cells
Release of TGF-β alone by dendritic cells leads to formation of Treg cells
Treg cells release TGF-β + IL-10 to suppress the formation of TH1, TH2, and TH17 cells
Activated TH2 cells released TGF-β, IL-4 and IL-10 [discrepancy between Kong and Sundick]
Can be secreted by tumor cells in tumor-induced immunosuppression (suppress T cell function)
TNF-α
Released by:
Local and systemic effects:
(Kong’s lecture)
PROINFLAMMATORY
Released by activated macrophages; released by dendritic cells in response to uptake of infectious agents
- Local: activates vascular endothelium by inducing adhesion molecules- selectins (E), ICAMs (E), integrins (L); induce permeability (promotes diapedesis)
- Systemic: fever and shock
Produced by NK cells (Kong’s Tumor Immunity lecture)
TNF-β (Lymphotoxin)
Promotes:
Released by:
Promotes diapedesis of fresh macrophages to site of infection
Released by activated TH1 cells in delayed-type hypersensitivity reaction against tissue grafts (cytotoxic to graft)
GM-CSF
Released as a preformed substance by mast cells during type I hypersensitivity
Macrophage differentiation in bone marrow
C5a
Chemotactic factor for PMNs; vasoactive; activate mast cells
C3a
Vasoactive; activate mast cells
C2b
Buildup causes swelling (as seen in C1 inhibitor deficiency- hereditary angioneurotic edema)
ECF
Eosinophilic chemotactic factor; preformed substance in mast cells
Thromboxanes/Prostaglandins
Chemotactic for PMNs and eosinophils